$67.95 +2.17 (3.30%)
Palvella Therapeutics, Inc. Common Stock (PVLA)
Palvella Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for dermatological and other dermatology-related diseases. It specializes in innovative topical treatments aimed at addressing unmet medical needs in skin-related conditions.
Company News
Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development
Ebenbuild's digital twin technology Twinhale was used in a study published in Nature Communications, demonstrating the potential of inhaled therapeutics for treating idiopathic pulmonary fibrosis (IPF). The simulations revealed how the novel inhaled Anticalin® protein PRS-220 can effectively target diseased lung tissue, paving the way for more e...